Charles Zhou
Stock Analyst at UBS
(0.36)
# 2630
Out of 5,370 analysts
13
Total ratings
42.86%
Success rate
-1.80%
Average return
Main Sectors:
Top Industries:
Name | Action | PT | Current | % Upside | Ratings | Updated | |
---|---|---|---|---|---|---|---|
FUTU Futu Hldgs | Maintains: Strong Buy | 130 136 | 123.56 | 10.07% | 3 | Mar 17, 2025 | |
ZYME Zymeworks | Reiterates: Buy | 16 | 12.62 | 26.78% | 1 | Mar 8, 2023 | |
COGT Cogent Biosciences | Initiates Coverage On: Buy | 15 | 7.46 | 101.07% | 1 | Jun 28, 2022 | |
MGNX Macrogenics | Downgrades: Neutral | n/a | n/a | n/a | 1 | May 5, 2022 | |
PMVP PMV Pharma | Initiates Coverage On: Buy | 56 | 1.07 | 5133.64% | 1 | Aug 2, 2021 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Buy | 46 | 1.46 | 3050.68% | 1 | Jun 28, 2021 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Neutral | n/a | n/a | n/a | 2 | Jan 22, 2020 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Upgrades: Neutral | n/a | n/a | n/a | 3 | Aug 25, 2017 |